High METTL14 expression in ccRCC patients is significantly (p < 0.05) associated with several clinicopathologic parameters including male (OR = 0.573), low grade (OR = 0.338), low stage (OR = 0.310), low T stage (OR = 0.318) and more distant metastasis (OR = 0.467). Here, METTL14 is linked to nonpapillary renal cell carcinoma.